Venture capital houses Omnes Capital, Principia and Seventure, alongside Nestlé Health Science, have invested in a €46.3m series-E round for French biotech company Enterome.
Omnes, Principia, Seventure in €46.3m series-E for Enterome
Most Popular
Venture capital houses Omnes Capital, Principia and Seventure, alongside Nestlé Health Science, have invested in a €46.3m series-E round for French biotech company Enterome.